Plaza Park Family Practice Llc | |
3799 Venetian Way Newburgh IN 47630-8278 | |
(812) 471-4302 | |
(812) 471-4303 |
Full Name | Plaza Park Family Practice Llc |
---|---|
Speciality | Family Medicine |
Location | 3799 Venetian Way, Newburgh, Indiana |
Authorized Official Name and Position | Carleen M Rubel (PRESIDENT) |
Authorized Official Contact | 8124714302 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Plaza Park Family Practice Llc Po Box 3276 Evansville IN 47731-3276 Ph: (812) 473-0181 | Plaza Park Family Practice Llc 3799 Venetian Way Newburgh IN 47630-8278 Ph: (812) 471-4302 |
NPI Number | 1336574490 |
---|---|
Provider Enumeration Date | 09/09/2013 |
Last Update Date | 02/27/2024 |
Medicare PECOS PAC ID | 4981830585 |
---|---|
Medicare Enrollment ID | O20131203001040 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.
Cocaine, already a damaging drug for those with healthy immune systems, can be lethal for those living with human immunodeficiency virus. Mudit Tyagi, Ph.D., assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, has received two federally funded grants to study how dangerous this combination is in HIV patients.
Scientists have successfully treated flies displaying behavioral problems linked to newly discovered schizophrenia-associated genes in humans, using common anti-psychotics.
› Verified 7 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1336574490 | NPI | - | NPPES |
DU3406 | Other | IN | RAILROAD MEDICARE |
000000840875 | Other | IN | ANTHEM |
201195100 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 01036788A (Indiana) | Primary |
363L00000X | Nurse Practitioner | (Indiana) | Secondary |
Provider Name | Carleen M Rubel |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1114904380 PECOS PAC ID: 3971523523 Enrollment ID: I20070409000516 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.
Cocaine, already a damaging drug for those with healthy immune systems, can be lethal for those living with human immunodeficiency virus. Mudit Tyagi, Ph.D., assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, has received two federally funded grants to study how dangerous this combination is in HIV patients.
Scientists have successfully treated flies displaying behavioral problems linked to newly discovered schizophrenia-associated genes in humans, using common anti-psychotics.
› Verified 7 days ago
Provider Name | Shannon L Kratzer |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1871821629 PECOS PAC ID: 6800921073 Enrollment ID: I20100914000752 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.
Cocaine, already a damaging drug for those with healthy immune systems, can be lethal for those living with human immunodeficiency virus. Mudit Tyagi, Ph.D., assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, has received two federally funded grants to study how dangerous this combination is in HIV patients.
Scientists have successfully treated flies displaying behavioral problems linked to newly discovered schizophrenia-associated genes in humans, using common anti-psychotics.
› Verified 7 days ago
Provider Name | Elise R Schutt |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1215237565 PECOS PAC ID: 6800050493 Enrollment ID: I20120612000010 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.
Cocaine, already a damaging drug for those with healthy immune systems, can be lethal for those living with human immunodeficiency virus. Mudit Tyagi, Ph.D., assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, has received two federally funded grants to study how dangerous this combination is in HIV patients.
Scientists have successfully treated flies displaying behavioral problems linked to newly discovered schizophrenia-associated genes in humans, using common anti-psychotics.
› Verified 7 days ago
Provider Name | Courtney N Bender |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1538455027 PECOS PAC ID: 0446405682 Enrollment ID: I20140811000879 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.
Cocaine, already a damaging drug for those with healthy immune systems, can be lethal for those living with human immunodeficiency virus. Mudit Tyagi, Ph.D., assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, has received two federally funded grants to study how dangerous this combination is in HIV patients.
Scientists have successfully treated flies displaying behavioral problems linked to newly discovered schizophrenia-associated genes in humans, using common anti-psychotics.
› Verified 7 days ago
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.
Cocaine, already a damaging drug for those with healthy immune systems, can be lethal for those living with human immunodeficiency virus. Mudit Tyagi, Ph.D., assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, has received two federally funded grants to study how dangerous this combination is in HIV patients.
Scientists have successfully treated flies displaying behavioral problems linked to newly discovered schizophrenia-associated genes in humans, using common anti-psychotics.
› Verified 7 days ago
Deaconess Clinic Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4011 Gateway Blvd, Newburgh, IN 47630 Phone: 812-490-4570 Fax: 812-490-4570 | |
Doctors Bose And Bose Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1800 Waters Ridge Dr, Newburgh, IN 47630 Phone: 812-470-1063 | |
Deaconess Gibson Gastro Gateway Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4219 Gateway Blvd, Newburgh, IN 47630 Phone: 812-842-2701 Fax: 812-842-2717 | |
Neff Health Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8788 Ruffian Ln Ste B, Newburgh, IN 47630 Phone: 812-492-1960 | |
Deaconess Care Group At Heart Hospital Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4007 Gateway Blvd, Newburgh, IN 47630 Phone: 812-842-4784 Fax: 812-842-3921 | |
Orthopaedic Associates, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4011 Gateway Blvd Ste 100, Newburgh, IN 47630 Phone: 812-424-9291 | |
Deaconess Clinic I Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4011 Gateway Blvd Ste 100, Newburgh, IN 47630 Phone: 812-858-2100 Fax: 812-858-2120 |